Cancer Immunotherapy Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CHM | F | Chimeric Therapeutics Limited NL | -4.55 | |
IMM | B | Immutep Limited | 4.60 | |
IMU | F | Imugene Limited | 1.41 |
Related Industries: Biotechnology
Date | Stock | Title |
---|---|---|
May 15 | IMM | Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024 |
- Cancer Immunotherapy
Cancer immunotherapy (sometimes called immuno-oncology) is the artificial stimulation of the immune system to treat cancer, improving on the system's natural ability to fight cancer. It is an application of the fundamental research of cancer immunology and a growing subspecialty of oncology. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules (e.g. carbohydrates). Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill.
Recent Comments
- SwingTradeBot on Market Recap for Wednesday, February 28, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
- SwingTradeBot on Market Recap for Friday, February 23, 2024
- SwingTradeBot on Market Recap for Thursday, February 22, 2024
From the Blog
Featured Articles